The physicians in the Stem Cell Transplant Program believe in the importance of clinical research to validate and improve outcomes and to offer new options to our patients. Weill Cornell Medical College conducts more clinical studies in hematological malignancies (leukemia, myeloma, lymphoma) than any of our regional peers, and the transplant program is an important contributor.

We conduct state-of-the-art clinical trials to find the best treatments for our patients, and we have access to high priority studies from regional and national cooperative groups. In addition, we work in close collaboration with world-class experts in the Leukemia, Lymphoma and Myeloma programs at NewYork-Presbyterian/Weill Cornell to design studies for those most in need.

The clinical trial protocols available are a mixture of investigator-initiated trials (i.e. Cornell-specific), pharmaceutical studies, and collaborative, mutli-institutional trials. Below is a list of currently open clinical trials. Click the links on the study titles to view detailed information about the studies, including key eligibility and the physician leading the study.

If you are interested in participating in a BMT service clinical trial, or for more information about our studies, please contact June Greenberg, RN at (212) 746-2651, or email at jdg2002@med.cornell.edu.

For a list of current BMT Clinical Trials, please follow the link below:

http://cornellmedicine.com/trials/cancer-and-blood-disorders/bone-marrow-transplant-bmt